Yutaka Shoji Selected Research

Yutaka Shoji Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 01/2002
4	Endometriosis 02/2010 - 10/2005
4	Colonic Neoplasms (Colon Cancer) 03/2006 - 01/2002
3	Carcinogenesis 03/2006 - 01/2002
2	Intestinal Polyps 11/2003 - 09/2003
2	Polyps 11/2003 - 09/2003
2	Hyperlipidemias (Hyperlipidemia) 11/2003 - 09/2003
1	Obesity 01/2021
1	Hyperammonemia 10/2016
1	Lysinuric Protein Intolerance 10/2016
1	Endometrial Neoplasms (Endometrial Cancer) 02/2015
1	Methylmalonic acidemia 04/2007
1	Carcinoma (Carcinomatosis) 04/2007
1	Cataplexy 07/2006
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 07/2006
1	Colorectal Neoplasms (Colorectal Cancer) 03/2006
1	Diabetes Mellitus 11/2004
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2003
1	Intestinal Polyposis (Polyposis, Intestinal) 09/2003
1	Aberrant Crypt Foci 01/2002

Drug/Important Bio-Agent (IBA)

4	ProstaglandinsIBA 01/2007 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 10/2016 - 10/2005
2	TeaIBA 01/2021 - 11/2004
2	CholesterolIBA 07/2006 - 09/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2006 - 10/2003
2	AzoxymethaneIBA 03/2006 - 01/2002
2	Prostaglandins EIBA 12/2005 - 01/2002
2	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 12/2005 - 01/2002
2	PPAR gammaIBA 11/2003 - 09/2003
2	Pioglitazone (Actos)FDA Link 11/2003 - 09/2003
2	LigandsIBA 11/2003 - 09/2003
1	PolyphenolsIBA 01/2021
1	Coffee FDA Link 01/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 10/2016
1	Amino Acids FDA Link 10/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2016
1	MicroRNAs (MicroRNA)IBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2012
1	Serine (L-Serine)FDA Link 01/2012
1	Dinoprostone (PGE2)FDA Link 02/2010
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2009
1	TegafurIBA 04/2007
1	Leucovorin (Folinic Acid)FDA Link 04/2007
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2007
1	UracilIBA 04/2007
1	Methylmalonyl-CoA MutaseIBA 04/2007
1	OrexinsIBA 07/2006
1	LipidsIBA 07/2006
1	7- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA 03/2006
1	HeptanesIBA 03/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2006
1	EnzymesIBA 10/2005
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2005
1	GelatinasesIBA 10/2005
1	Troglitazone (Rezulin)FDA Link 11/2003
1	PPAR-gamma AgonistsIBA 11/2003
1	NF-kappa B (NF-kB)IBA 10/2003
1	PPAR alphaIBA 09/2003
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2003
1	Triglycerides (Triacylglycerol)IBA 09/2003
1	BezafibrateIBA 09/2003
1	ONO-AE1-329IBA 01/2002
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2002
1	CarcinogensIBA 01/2002
1	Messenger RNA (mRNA)IBA 01/2002

Therapy/Procedure

1	Lasers (Laser) 02/2015
1	Therapeutics 04/2007
1	Oral Administration 04/2007
1	Neoadjuvant Therapy 04/2007